Global Bovine Respiratory Disease Treatment Market Report, History and Forecast 2013-2025, Breakdown Data by Companies, Key Regions, Types and Application

City of Industry, CA -- (SBWire) -- 07/13/2018 --This report studies the Bovine Respiratory Disease Treatment market size by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired host immunity, inadequate housing conditions, and environmental factors. The major factor leading to bovine respiratory diseases are host factors, environmental factors, and direct influence of infectious agents such as virus, bacteria, and parasites. However, due to increasing consumption of milk and beef products, the need for bovine respiratory disease treatment has increased across the globe.

Request Sample Copy of the Report @ https://www.qyresearch.com/sample-form/form/573800/global-bovine-respiratory-disease-treatment-market

One of the major factors responsible for the market's growth is the increasing interests of several vendors on the development of novel drugs to gain a competitive advantage over their competitors. For instance, Bayer HealthCare launched Zelnate in the US, which is a bacterial-produced plasmid DNA including a liposome carrier that helps to stimulate the innate immune system in cattle. Furthermore, under traditional antibiotics segment also, vendors are launching various drugs such as draxxin for the cattle respiratory disease treatment. The growing focus on the development of combination drugs will drive the growth prospects for the global BRD treatment market for the next few years. Some of the major factors responsible for the growing number of development of combination drugs is the need to offer improved efficacy and ensure better treatment outcomes.

North America accounts for a major share in the global market, of which around 90% is held by the U.S. alone. The bovine respiratory disease treatment market in the U.S. is propelled by the rising domestic production, consumption, and export of bovine meat.

In 2017, the global Bovine Respiratory Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% between 2018 and 2025.

Ask for Discount on Research Report@ https://www.qyresearch.com/request-discount/form/573800/global-bovine-respiratory-disease-treatment-market

This report focuses on the global top players, covered

Bayer HealthCare

Boehringer Ingelheim

Elanco

Merck

Zoetis

Ceva

Inovio Pharmaceuticals

Norbrook Laboratories

Plumbline Life Sciences

Market segment by Regions/Countries, this report covers

North America

Europe

China

Rest of Asia Pacific

Central & South America

Middle East & Africa

Market segment by Type, the product can be split into

Vaccines

Antibiotics

Immunomodulators

Others

Market segment by Application, the market can be split into

Veterinary Clinics

Veterinary Hospitals

Veterinary Research Institutes

Private Veterinary Pharmacies